{"denomUnitsSelected":"Participants","description":"Continuous biomarker levels will be explored in a graphical manner including mean plots and plots of change and percent change from baseline and other summary measures. Any potential relationships between the baseline level or change in the level of each biomarker and clinical outcome such as confirmed overall response, 6-month progression-free survival, and adverse event incidence will be further analyzed using Wilcoxon rank sum tests or logistic regression methods, as appropriate. Association between a mutation status and confirmed overall response will be assessed using a chi-squared test.","reportingStatus":"NOT_POSTED","timeFrame":"Baseline up to 1 year","title":"Degradation of cIAP1 in PBMC","type":"OTHER_PRE_SPECIFIED"}